Skip to main content
Caplight Logo









Erisyon

Erisyon

Private
Austin, TexasHealthcare & Life Scienceshttps://www.erisyon.com/

Last Round

Grant

Jan 7, 2025

Total Funding Raised

$3.08M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Erisyon Inc. is a biotechnology company that is commercializing a single-molecule protein sequencing platform to detect, treat, and track disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

single-molecule protein sequencingprotein sequencing platformFluorosequencingproteomicsnext-generation proteomicsbiomarker discoveryprotein sequencerabsolute quantificationlife science toolsmass spectrometry alternativelow-abundance protein detectionpost-translational modificationsbiotech equipmentdrug discoveryrazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Erisyon Comparables

Compare Erisyon with similar companies based on industry and business-model similarity.

Erisyon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genopore
88%
Encodia
87%
Primary Bioscience
86%

Erisyon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 7, 2025
GrantSep 22, 2022
SeedNov 30, 2020
GrantJun 1, 2020
GrantMay 14, 2020

Key People

Founding team and executive leadership

Jagannath Swaminathan

Co-Founder And Chief Technology Officer

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 148% MoM, reaching 1.4K.

  • May 4, 2025

    Monthly visitors grew 580% MoM, reaching 1.4K.

Erisyon Filings

Explore SEC and related filing metadata, where available.

Erisyon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Erisyon's valuation, stock price, and market status.

Is Erisyon a public or private company?

Erisyon is a private company.

What is the current stock price of Erisyon?

Erisyon is a private company with no public stock price. No recent secondary market data is available.

How much is Erisyon worth (valuation)?

Valuation information for Erisyon is not publicly available.

Can I buy Erisyon stock?

Erisyon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Erisyon's last funding round?

Funding round information for Erisyon is not publicly available.

Who are the main investors in Erisyon?

Investor information for Erisyon is not publicly disclosed.

Will Erisyon IPO soon?

No public IPO plans have been announced for Erisyon.

How can I track Erisyon secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Erisyon's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAustin, Texas
Employee Range8
Year Founded2018
Last FundingJan 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?